Xingsheng Shu
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 20, 2024
FXR-regulated COX6A2 triggers mitochondrial apoptosis of pancreatic β-cell in type 2 diabetes.Lianqi Shao, Xiangchen Kong, Simian Lv
|Jan 19, 2024
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.Yongheng Chen, Ying Ying, Wenlong Ma
|Jan 07, 2023
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer.Yongheng Chen, Ying Ying, Maolin Wang
|Nov 11, 2022
Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities.Fangfei Xiao, Xuefeng Gao, Hui Hu
|May 23, 2022
Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci.Ying Ying, Maolin Wang, Yongheng Chen
|Sep 24, 2017
The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.Xing-Sheng Shu, Yingying Zhao, Yanmei Sun
Pageof 1
